Honored to present ‘Survival after simple vs. radical hysterectomy for early-stage cervical cancer’ at the Society of Pelvic Surgeons’ Annual Meeting. A collaborative effort alongside urology and surgical colleagues. Check it out: journals.lww.com/greenjournal/a… David Viveros-Carreño

#cancer during #pregnancy is associated with severe maternal and neonatal morbidity. Proud of the entire team for this important manuscript! authors.elsevier.com/c/1k7m2gm3zE9I J. Alejandro Rauh-Hain, MD, MPH Alex Melamed @markaclapp Abigail S. Zamorano, MD MPHS David Viveros-Carreño Núria Agustí Garcia MD Anderson Cancer Center AJOG

Happy to have contributed to this updated SR on SLN in ovarian cancer, a complex technique requiring distinct methodology, developed alongside colleagues with expertise in this area. There is still so much to learn! #OvarianCancer Victor Lago Nicolò Bizzarri Berta Diaz Feijoo

LANCE trial lead-in pilot shows the feasibility of a phase III study to evaluate the efficacy of MIS for interval cytoreduction in ovarian cancer. J. Alejandro Rauh-Hain, MD, MPH Anna Fagotti René Pareja Pedro T Ramirez Abdulrahman K. Sinno

Excited to share our Green Journal publication! For low-risk #CervicalCancer patients (tumors ≤2 cm), SH showed no compromise in OS in the NCDB. A step forward for less radical approaches. Grateful for the amazing teamwork, particularly with David Viveros-Carreño 🤝📚 #GynOnc

Our 15-year cohort study explores trends in surgical de-escalation in gynecologic oncology. These findings are transforming patient care but raise important questions about the preparation of fellows in surgical training. Alex Melamed David Viveros-Carreño J. Alejandro Rauh-Hain, MD, MPH Roni Nitecki Wilke

Emotivo e riuscito congresso. Felice di aver avuto l’opportunità di presentare e di rivedere tutti i colleghi internazionali. Great to exchange insights and reconnect with colleagues! #esgo2025

🎙️ Listen to this week's #IJGC podcast as Pedro T Ramirez dives into the LANCE Trial breaking down the results of the Feasibility Phase with J. Alejandro Rauh-Hain, MD, MPH 🎧 bit.ly/41vrCTD Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists

Last but not least, we were fortunate enough to speak with Núria Agustí Garcia, MD, of MD Anderson Cancer Center, about her study on adjuvant CRT vs radiotherapy alone in intermediate-risk cervical cancer. One more day of interviews to go, so be sure to tune in tomorrow! SGO #SGO2025

Great presentation on our JAMA Network Open study about surgical trends and future directions in our field! Even better to share this experience in such a beautiful city with wonderful colleagues. #sgo2025 #SGOMtg

Excited about our JAMA Oncology study! Adding CHT to RT showed no OS benefit in intermediate-risk cervical cancer, aligning with GOG 263 (#SGO2025). Hope this helps refine guidelines & improve patient care. David Viveros-Carreño Alex Melamed Roni Nitecki Wilke René Pareja J. Alejandro Rauh-Hain, MD, MPH

At #ESGO2025 we introduced a model using tumor size, grade & LVSI to predict LN metastasis in early-stage cervical cancer—streamlining treatment planning and reducing dual therapy. Check it out: vumedi.com/video/esgo-202… via @vumedi

Cervical Cancer treatment studies show no survival advantage of chemoradiotherapy over radiotherapy alone. These results support a more selective approach, reducing unnecessary toxicity for patients with intermediate-risk cervical cancer JAMA Oncology 👉 bit.ly/3YC63yO

🚨Exploring ADCs in Platinum-Resistant Ovarian Cancer: Prof Ray-Coquard & Dr Agustí & Dr Strojna Link: buff.ly/1zo5Kdg

The addition of chemotherapy to radiotherapy was not associated with improved survival among patients with intermediate-risk #cervicalcancer, according to data published in JAMA Oncology. 🔗 Healio spoke with Núria Agustí Garcia of MD Anderson Cancer Center about the data bit.ly/42XMzpT

Our JAMA Oncology study is now featured in the IJGC podcast! Thank you for highlighting our work. Grateful to work with such an amazing team! David Viveros-Carreño Alex Melamed Roni Nitecki Wilke René Pareja J. Alejandro Rauh-Hain, MD, MPH

Do not miss this article on a common problem in Latinoamérica, and maybe in every low income country. Choices are presented according to the type of disease found. Remember: Hysterectomy NEVER be the first choice for cervical dysplasia, we know this since more than 20 years ago,

King Carlos 👑 The Spaniard defeats Sinner in four sets to claim his second US Open trophy!

New from Team Ovary!🧬 Our feasibility study in Obstetrics & Gynecology explores optimal injection techniques for ovarian sentinel lymph node mapping using ICG. Findings support IP ligament injection as a feasible approach for future studies. 📄pubmed.ncbi.nlm.nih.gov/41037815/